First North provides infrastructure for trading and distributing share information. In order to be quoted on First North, a company must appoint a Certified Adviser who pilots the company through the application process and ensures that the company lives up to and continuously complies with the acquis. The Certified Adviser ensures that the company meets the entry requirements and the ongoing obligations associated with the company’s shares are approved for trading on First North. In addition, the Certified Adviser continually monitors the company’s compliance and reports immediately to the exchange if any rule is breached.
Amudova AB is Certified Adviser for SpectraCure AB.
For more information about Amudova AB See https://amudova.se/
SpectraCure is developing the future systems for the treatment of internal solid cancer tumours. The goal of the proprietary and patented treatment system is to eliminate deep-seated cancer tumours and prolong the survival of cancer patients while maintaining their quality of life. When prostate cancer recurs, there are often no established treatment options other than lifelong hormone therapy, with its associated side effects.